Imaging Biochemistry Noninvasively: Magnetic Resonance Spectroscopy in Liver Disease

Abstract

Get full access to this article

View all access options for this article.

References

Woodward JM, Priest AN, Hollingsworth KG, Lomas DJ. Clinical application of magnetic resonance spectroscopy of the liver in patients receiving long term parenteral nutrition. JPEN J Parenter Enteral Nutr. 2009;33:669 -676.

Taylor-Robinson SD. Application of magnetic resonance spectroscopy to chronic liver disease. Clin Med.2001 ;1:54 -60.

Ross BD, Radda GK, Gadian DG, Rocker G, Esiri M, Falconer-Smith J. Examination of a case of suspected McArdle's disease by 31P nuclear magnetic resonance. N Engl J Med.1981 ;304:1338 -1342.

Fischbach F, Bruhn H. Assessment of in vivo 1H magnetic resonance spectroscopy in the liver: a review. Liver Int.2008 ;28:297 -307.

Solga SF, Horska A, Clark JM, Diehl AM. Hepatic 31P magnetic resonance spectroscopy: a hepatologist's user guide. Liver Int.2005 ;25:490 -500.

Szczepaniak LS, Nurenberg P, Leonard D, et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab. 2005;288:E462 -E468.

Thomas EL, Hamilton G, Patel N, et al. Hepatic triglyceride content and its relation to body adiposy: a magnetic resonance imaging and proton magnetic resonance spectroscopy study. Gut.2005 ;54:122 -127.

Johnson NA, Walton DW, Sachinwalla T, et al. Noninvasive assessment of hepatic lipid composition: advancing understanding and management of fatty liver disorders. Hepatology.2008 ;47:1513 -1523.

Cho SG, Kim MY, Kim HJ, et al. Chronic hepatitis: in vivo proton MR spectroscopic evaluation of the liver and correlation with histopathologic findings. Radiology.2001 ;221:740 -746.

10.

Lim AK, Patel N, Hamilton G, Hajnal JV, Goldin RD, Taylor-Robinson SD. The relationship of in vivo 31P MR spectroscopy to histology in chronic hepatitis C. Hepatology.2003 ;37:788 -794.